Delivery Order SPE2DB20D3103-SPE2DB23FN2L0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,674.67 firm fixed-price delivery order is for the supply of 4,564,690 units of Duloxetine HCL DR 40 mg capsules. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.68 firm-fixed-price delivery order is for the supply of 4567655738 - Duloxetine HCL DR 40 MG Capsules, 30s. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.99 firm fixed-price delivery order is for the supply of 4564860751 - Duloxetine HCL DR 40 MG Capsules in quantities of 30s. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,116,695 units of Duloxetine HCl DR 40 mg capsules. The $3,699.63 Firm Fixed Price delivery order contract runs through February 3, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a broad range of pharmaceutical...
- This federal contract award is for the delivery of 4,563,455,569 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,313.22 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order for the supply of Duloxetine HCl DR 40 mg capsules. The award, valued at $1,483.26, has an ultimate completion date of May 14, 2025 and is not set aside for any particular type of business. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $8,116.49, is for the delivery of Duloxetine HCL DR 60 MG capsules, with an ultimate completion date of April 28, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,692,596 units of Duloxetine HCL DR 40 MG capsules, a medication used to treat various conditions. The contract has a total ceiling value of $1,342.68 and runs through December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Duloxetine HCl DR 40 mg capsules. The contract has a ceiling value of $1,022.54 and a performance period extending through June 18, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Duloxetine HCL DR 40 mg capsules. The contract has a firm fixed price of $1,356.00 and an ultimate completion date of August 23, 2024. It is a delivery order contract and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, is a significant supplier of pharmaceutical products and medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN2L0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,149.02 for the supply of 4,560,778,971 units of Duloxetine HCL DR 30 mg Capsules. The contract was issued by the Defense Logistics Agency (DLA) and has a period of performance through May 2, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This delivery order is issued under that broader IDC. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 5/1/23 |